 |
Previous Article | Next Article 
Volume 16, Number 19,
Issue of October 1, 1996
pp. 6208-6218
Copyright ©1996 Society for Neuroscience
TrkA, But Not TrkC, Receptors Are Essential for Survival of
Sympathetic Neurons In Vivo
Anne M. Fagan1,
Hong Zhang2,
Story Landis2,
Richard J. Smeyne1,
Inmaculada Silos-Santiago1, and
Mariano Barbacid1
1 Department of Molecular Oncology, Bristol-Myers
Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543, and 2 Department of Neuroscience, Case Western Reserve
University, Cleveland, Ohio 44195
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Neurotrophins and their signaling receptors, the Trk family of
protein tyrosine kinases, play a major role in the development of the
mammalian nervous system. To determine the precise stages that require
Trk receptor signaling during development of the sympathetic system, we
have analyzed the superior cervical ganglion (SCG) of embryonic and
postnatal mice defective for each of the known Trk receptors.
Transcripts encoding TrkC are detected in early sympathetic
development, before the coalescence of the SCG. trkA
expression appears at E13.5, becoming robust from E15.5 onward. In
contrast, trkC expression decreases significantly after
E15.5 and remains detectable only in a small subpopulation of cells. No
significant trkB expression could be detected in the SCG
at any developmental stage. Ablation of TrkA receptors does not affect
neurogenesis, expression of neuronal markers, or initial axonal growth.
However, these receptors are absolutely necessary for the survival of
sympathetic neurons after E15.5 and for proper innervation of their
distal targets. In contrast, mice defective for either TrkC or TrkB
tyrosine kinase receptors do not display detectable defects in their
SCGs. These results illustrate the differential roles of the Trk family
of receptors during SCG development and define a critical role for TrkA
signaling in the survival, but not differentiation, of SCG neurons.
Moreover, these observations raise the possibility that at least some
SCG neurons become neurotrophin-dependent before complete target
innervation.
Key words:
Trk receptors;
neurotrophins;
superior
cervical ganglion;
sympathetic neurons;
neuronal survival;
knockout
mice
INTRODUCTION
Neurotrophins are trophic factors necessary for
the development of the vertebrate nervous system. These molecules are
abundantly expressed in neural regions during embryonic development
(Ernfors et al., 1992 ; Schecterson and Bothwell, 1992 ; Elkabes et al.,
1994 ) and are likely to act by promoting the differentiation and/or
survival of developing neurons (for review, see Barde, 1989 ; Korsching,
1993 ; Snider, 1994 ). In vitro studies have shown that early
in development, neuronal survival is neurotrophin-independent. However,
neurons become neurotrophin-dependent at later developmental stages
(Coughlin and Collins, 1985; Ernsberger et al., 1989 ; Wyatt and Davies,
1993 ), often concomitant with the timing of target innervation (Vogel
and Davies, 1991 ).
Neurotrophins exert their trophic actions by interacting with
two classes of cell surface receptors. The Trk family of tyrosine
protein kinase receptors are the primary mediators of neurotrophin
signaling and provide functional specificity (for review, see Barbacid,
1994 ). For instance, whereas the TrkA receptor primarily recognizes
nerve growth factor (NGF), TrkB mediates signaling of brain-derived
neurotrophic factor (BDNF) and neurotrophin-4/5 (NT-4/5). TrkC
receptors specifically interact with NT-3, a neurotrophin that can also
activate TrkA and TrkB receptors under certain conditions (Barbacid,
1994 ). Each of the neurotrophins also binds with low affinity to
another receptor, p75, a member of the TNF receptor family (Chao,
1994 ). The role of p75 in mediating neurotrophin function is still not
fully resolved (Chao, 1994 ).
Recently, mice carrying targeted mutations in the genes encoding each
of the known neurotrophins and their cognate receptors have been
generated (Barbacid, 1994 ; Snider, 1994 ). These animals provide unique
experimental tools with which to explore the role of trophic factor
signaling during development of the nervous system. One of the most
amenable systems to study neuronal development is the superior cervical
ganglion (SCG), a major component of the mammalian sympathetic system.
The SCG has been well characterized anatomically and functionally.
Unlike sensory ganglia, the SCG contains primarily one class of
neurons, principal sympathetic neurons. Early in development,
sympathetic neurons and their precursors respond in vitro to
NT-3 (Birren et al., 1993 ; DiCicco-Bloom et al., 1993 ). However, during
late gestation they become dependent on NGF for survival, both in
vitro (Levi-Montalcini and Angeletti, 1966 ; Chun and Patterson,
1977 ) and in vivo (Levi-Montalcini and Booker, 1960 ; Gorin
and Johnson, 1980 ). The critical role of the NGF/TrkA signaling pathway
in sympathetic development in vivo has been illustrated
recently. Ablation of genes encoding either NGF (Crowley et al., 1994 )
or its signaling receptor TrkA (Smeyne et al., 1994 ) results in the
virtual absence of SCG neurons by the first postnatal week. NT-3
null mice also exhibit a sympathetic defect. These mice have
~50% fewer SCG neurons (Ernfors et al., 1994 ; Fariñas et al.,
1994 ), consistent with the observation that NT-3 promotes the survival
of sympathetic neuroblasts in culture (Birren et al., 1993 ;
DiCicco-Bloom et al., 1993 ; Verdi and Anderson, 1994 ).
In this study, we have examined the role of neurotrophin signaling
during development of the mammalian sympathetic system by analyzing the
SCG of mice lacking functional TrkA, TrkB and TrkC receptors. We report
that TrkB and TrkC receptors are not required for normal sympathetic
development in vivo. TrkA receptors are not necessary for
the proliferation of SCG neuronal precursors or for their subsequent
postmitotic differentiation into sympathetic neurons. However, these
receptors are absolutely required for sympathetic neuron survival
during late embryogenesis and early postnatal development.
TrkA-deficient sympathetic neurons do not reach some of their distal
targets, suggesting that these neurons become trophic factor-dependent
before complete target innervation.
MATERIALS AND METHODS
Tissue processing. Mice were analyzed at embryonic
day 11.5 (E11.5), E13.5, E15.5, E17.5, postnatal day 0 (P0), P5, P9,
and P16. Embryos were obtained via Caesarean section from timed matings
of trkA+/ (Smeyne et al., 1994 ),
trkC+/ (Klein et al., 1994 ), or
trkB+/ (Klein et al., 1993 ) heterozygous mice
and fixed in 4% paraformaldehyde in 0.1 M PBS. Animals
younger than E15.5 were fixed via immersion. All others were perfused
transcardially and fixed overnight in the same fixative. Heads or
dissected SCGs were either embedded in paraffin or cryoprotected in
30% sucrose in PBS.
Histological analysis. Paraffin sections (5 µm) through
the SCGs of wild-type animals and mutant animals at each developmental
time point were stained with 0.2% cresyl violet and used for neuronal
counts. Neuron numbers were determined by counting neuronal profiles
exhibiting a visible nucleus and nucleolus in every fifth section. Raw
counts were then corrected with a multiplication factor using section
thickness and the average nuclear diameter. Because values of wild-type
mice often vary between animals from different litters at a given
developmental age, values derived from mutant mice were always compared
(Student's t tests) with their own wild-type littermates.
The total number of mitotic figures and of pyknotic nuclei was also
calculated at each developmental time point.
Semithin sectioning and electron microscopy. Postnatal (P1
and P5) trkA / animals and normal littermate
controls were transcardially perfused with 4% paraformaldehyde and 3%
glutaraldehyde in 0.1 M PBS. SCGs were dissected free,
post-fixed, stained en bloc using 2% aqueous uranyl
acetate, dehydrated in ethanol, and embedded in Epon 812 (Electron
Microscopy Sciences). Semithin (0.5 µm) sections were stained with
toluidine blue. Thin sections were poststained with uranyl acetate and
lead citrate before they were viewed with the electron microscope.
In situ hybridization. In situ hybridization
analysis was performed using 33P-labeled cRNA probes
specific for trkA, trkB, and trkC cDNA
sequences. Paraffin-embedded tissue sections were mounted on Superfrost
Plus slides (Fisher Scientific, Houston, TX), deparaffinized, treated
with proteinase K (1 µg/ml at 37°C for 30 min), and acetylated with
0.25% acetic anhydride in 0.1 M triethanolamine with 0.9%
NaCl before hybridization. Sections were hybridized with 2 × 106 cpm of either antisense or sense probe (see below) for
16 hr at 52°C. Hybridized slides were rinsed twice in 4× SSC for 15 min at room temperature and digested with RNase A (20 µg/ml) for 30 min at 37°C. Slides were rinsed in TE buffer alone for 30 min at
37°C, washed in 2× SSC at 42°C for 15 min and in 0.1× SSC at
65°C for 15 min, dehydrated, air-dried, and exposed to Kodak XAR-5
film for 1-3 d before dipping in undiluted NTB-2 liquid emulsion
(Eastman Kodak, Rochester, NY). Slides were exposed at 4°C, developed
in D19 developer (Kodak), fixed in Kodak Fixer, dehydrated to xylenes,
and coverslipped. Probes were generated from the following plasmids:
(1) pMS44, a plasmid containing a 275 bp fragment encoding a portion of
the extracellular domain of a rat trkA cDNA clone; (2)
pFRK16, a plasmid containing a 500 bp fragment encoding a portion of
the extracellular domain of a mouse trkB cDNA clone; (3)
pFL25, a plasmid containing a 600 bp fragment encoding a portion of the
extracellular domain of a mouse trkC cDNA clone; and (4)
pFL26, a plasmid containing a 987 bp fragment encoding a portion of the
tyrosine kinase domain of a mouse trkC cDNA clone.
Immunocytochemistry. Immunocytochemistry for tyrosine
hydroxylase (TH) was performed on fixed, frozen tissue sections (14 µm thick). Sections were treated with 0.3%
H2O2 followed by blocking with 0.5% BSA in PBS
for 30 min at room temperature, and were incubated with a polyclonal
antiserum to TH (1:1000 dilution; Eugenetech) in 0.2% Triton X-100 in
PBS overnight at room temperature. Slides were then incubated for 1 hr
at room temperature with a biotinylated secondary antibody followed by
incubation with an avidin-biotin complex (Vector Laboratories,
Burlingame, CA). Sections were washed for 10 min twice with 0.5% BSA
in PBS between each step, rinsed twice in Tris-buffered saline (TBS),
and reacted in a solution of 2 ,2 ,4 -diaminobenzidine (0.25 mg/ml) in
TBS containing 0.015% H2O2 and 0.04% NiCl.
Stained sections were mounted, dehydrated to xylenes, and coverslipped.
RESULTS
Expression of trk genes in the developing SCG
To determine the temporal pattern of trk gene
expression in the developing mouse SCG, we carried out in
situ hybridization experiments using probes specific for each of
the three known members of the trk gene family. Low levels
of trkA hybridization could be detected first in the SCG at
E13.5, a time when this ganglion has just been formed. Robust
trkA expression was observed at E15.5 and maintained
throughout postnatal development (Fig. 1).
TrkC transcripts were already present in the sympathetic
chain at E11.5 and could be detected throughout the coalesced SCG at
E13.5. Significant levels of trkC expression remained in the
SCG of E15.5 embryos (Fig. 1). However, at birth trkC
expression had decreased significantly and was restricted to a small
number of cells (Fig. 1). Comparison of the relative numbers of cells
displaying trkC hybridization in E15.5 versus P0 mice
suggests that trkC expression is downregulated in most
neurons during late embryogenesis. Because the trkC gene
encodes several receptor isoforms, only some containing a tyrosine
kinase domain (Lamballe et al., 1993 ; Tsoulfas et al., 1993 ; Valenzuela
et al., 1993 ), we carried out additional in situ
hybridization studies using a probe specific for the trkC
tyrosine protein kinase sequences. This probe yielded similar results
(data not shown), indicating that most of the trkC
transcripts detected during SCG development correspond to those
encoding the signaling TrkC tyrosine kinase receptors. Finally,
trkB transcripts were not detected in sympathetic neurons at
any developmental time point despite abundant expression in neighboring
neuronal structures such as the nodose ganglion (data not shown).
Fig. 1.
Developmental expression of the
trkA and trkC genes in the SCGs of
wild-type mice as revealed by in situ hybridization.
Adjacent 5 µm paraffin tissue sections were hybridized with
33P-labeled riboprobes specific for trkA or
trkC. CV, Adjacent sections stained with
cresyl violet. Asterisks identify a landmark blood
vessel in each section for reference purposes. The
outline of the SCG in the dark-field sections is
indicated by a dotted line. ng, Nodose
ganglion; th, thyroid gland. Scale bars, 10 µm.
[View Larger Version of this Image (112K GIF file)]
SCG development in wild-type and trkA / embryos
Ablation of the trkA gene results in the almost
complete absence of sympathetic neurons in the SCG of postnatal
trkA / mice (Smeyne et al., 1994 ). To
determine the developmental stage at which trkA signaling is
required, we analyzed the SCGs of wild-type and
trkA / mice during embryonic and postnatal
development. As indicated above, the SCG does not coalesce into a
discrete ganglion until ~E13.5. At this time, SCG neuroblasts and
differentiating neurons are small and spherical and contain multiple
nucleoli (data not shown). The number of cells in the SCG increases
from E13.5 to E17.5 because of robust cellular proliferation as
determined by the high number of mitotic figures (Fig.
2). From E17.5 onward, the number of SCG neurons
increases slowly and stabilizes around birth because of a decrease in
the number of mitotic figures as well as an increasing number of
pyknotic nuclei, indicative of natural cell death (Fig. 2).
Fig. 2.
Quantification of (A) neuron
number, (B) mitotic figures, and (C)
pyknotic nuclei in the SCG of wild-type (filled
squares) and trkA / littermates
(open circles). Values were obtained from at least six
SCGs in each group for each time point. Asterisks
indicate statistically significant differences (Student's
t test, p < 0.05) between wild-type
and trkA / animals at a given time point.
Error bars correspond to SEM.
[View Larger Version of this Image (24K GIF file)]
Morphological examination of the sympathetic chain in
trkA / E11.5 embryos did not reveal any
obvious differences from those of their wild-type littermates.
Similarly, at E13.5 the number of neurons and neuroblasts in the
trkA / ganglia was indistinguishable from
that in control mice (Fig. 2A). Two days later, the
SCG of trkA / mice contained 15% fewer cells
than age-matched E15.5 wild-type embryos (Fig. 2A).
Quantitative analysis of mitotic figures and pyknotic nuclei indicates
that the reduction in neuron number is attributable to an increase in
the number of dying cells in the trkA / SCG
rather than to a decrease in the rate of cell proliferation (Fig.
2B,C).
By E17.5, we observed a dramatic difference between the SCGs of
wild-type and their trkA / littermates, with
~35% fewer cells in the mutant animals (Fig. 2A).
Again, the reduction in the number of neurons appears to be
attributable to an exacerbation of cell death rather than to a decrease
in cell division (Fig. 2B,C). By this
stage, the presence of mitotic figures has decreased considerably in
both normal and mutant mice. Neurons and neuroblasts within the SCG of
trkA / mice and their wild-type littermates
display similarly abundant immunoreactivity for the catecholamine
synthetic enzyme TH, indicating that these cells exhibit this
phenotypic marker in the absence of functional TrkA receptors.
SCG development in wild-type and trkA /
postnatal mice
By birth, trkA / mice exhibit ~50%
fewer SCG neurons than their wild-type littermates (Fig.
2A). This pattern of exacerbated cell death continues
postnatally, reaching a near complete loss of SCG neurons by P9 (Fig.
2A). During the early postnatal period (P5),
wild-type mice undergo a transient increase in the number of mitotic
figures, which likely represents proliferation of glial cells (Hendry,
1977 ; Hall and Landis, 1992 ) (Fig. 2). Interestingly, we did not
observe this increase in mitosis in the
trkA / animals. To determine the nature of
these dividing cells, P5 mice were injected twice with
bromodeoxyuridine (BRdU) and killed 2 hr later. Whereas the wild-type
ganglia displayed many BRdU labeled nuclei, ganglia from the
trkA / mice exhibited only a few labeled
cells (data not shown). Double labeling with TH antibodies revealed
that BRdU was not located in principal neurons but, rather, in
TH-negative non-neuronal cells (data not shown). These results indicate
that postnatal gliogenesis in the SCG is significantly reduced in
trkA / mice.
Morphological characterization of wild-type and
trkA / SCG neurons in postnatal mice
To characterize the defects observed in postnatal
trkA / animals, we analyzed the SCGs of
neonatal and P5 trkA / and wild-type
littermate animals in semithin sections (Fig. 3). At P1,
a majority of neurons in neonatal wild-type mice were medium in size
and ovoid in shape. They had large, eccentric nuclei with prominent
nucleoli and displayed abundant, moderately stained cytoplasm (Fig.
3A). Less mature neurons, characterized by smaller nuclei and less
cytoplasmic volume, were observed, as well as profiles of degenerating
neurons with darkly stained, condensed cytoplasm and nuclei, or having
a foamy appearance (Fig. 3A). Relatively few glial cell
profiles were evident at this time.
Fig. 3.
One micrometer semithin plastic sections of SCGs
of wild-type and trkA / mice.
A, P1 wild-type SCG. A majority of neurons are medium in
size and ovoid in shape (left arrowhead). A small
proportion of neurons are smaller and have less cytoplasm (right
arrowhead). The arrow indicates a degenerating
neuron. The thin arrow identifies a foamy cell.
B, P1 trkA / SCG. A
majority of neurons are small in diameter and irregular in shape
(arrowheads). Nuclei appear more darkly stained than
those of wild-type neurons, and little cytoplasm is evident. Neurons
also appear more closely clustered than those in sections of wild-type
ganglia. Many pyknotic cells are present (arrows).
C, P5 wild-type SCG. Neurons are significantly larger
than at P1, with increases in both nuclear and cytoplasmic volume. Both
satellite (arrows) and Schwann cells (thin
arrow) are prominent in association with cell bodies and axons,
respectively. D, P5 trkA /
SCG. Very few neurons remain. Those present display an immature
morphology similar to that observed in sections of P1 ganglia
(arrowheads). Cells with smaller and more darkly stained
nuclei resemble glial cells. Some pyknotic profiles remain
(arrows), but they are reduced in number in comparison
to P1. Magnification, 475×.
[View Larger Version of this Image (133K GIF file)]
In contrast, the SCG of P1 trkA / mice
had few, if any, cells with the appearance characteristic of maturing,
postmitotic sympathetic neurons. Instead, many of these cells resembled
embryonic neurons (Fig. 3B), small and irregularly shaped
with a relatively large rounded nucleus and only a thin rim of
cytoplasm. These cells could be distinguished from glial cells, which
had small, darkly stained and irregularly shaped nuclei (Fig.
3B). The mutant SCG also displayed many profiles of
degenerating cells with a dark, condensed nucleus and darkly stained
debris (Fig. 3B).
The morphological differences between the SCG of wild-type and
trkA / mice were even more striking at P5.
wild-type neurons had doubled or tripled in size and had one or more
satellite glial cells associated with their cell body (Fig.
3C). Very few neuronal profiles could be identified in
semithin sections of the P5 mutant ganglia, and those that were present
were very immature in appearance (Fig. 3D). Many cells in
the trkA / SCG had the appearance of glial
cells with darkly stained elongate nuclei and were associated with
lightly stained regions, presumably containing processes (Fig.
3D). Degenerating profiles were still common in the mutant
ganglia at this time, often appearing as darkly stained debris (Fig.
3D).
Ultrastructural analysis confirmed the morphological differences
between the cells of the wild-type and trkA /
SCG at P5 (Fig.
4A,B). No
mature-looking sympathetic neurons could be found in the P5
trkA / SCG (Fig. 4B), but
we did observe glial cells, fibroblasts, and small intensely
fluorescent (SIF) cells (see below) (Fig.
4B,C). Bundles of unmyelinated axons were
also observed in the SCG at this time (Fig.
4D,E). However, axons in the
mutant SCG were smaller in diameter and less well ensheathed than
those observed in the littermate controls (Fig.
4D,E).
Fig. 4.
Ultrastructural appearance of the SCGs of
wild-type and trkA / P5 mice.
A, P5 wild-type SCG. Neurons are large with abundant
organelles. Satellite cells are associated with neurons
(arrow). Bundles of axons (asterisk) are
present between the neuronal somata. B,
C, P5 trkA / SCG. There
are few cells with neuronal properties. The SCG is mostly comprised of
glial cells (arrows), fibroblasts, and SIF cells
(thin arrows) whose characteristic complement of
granules is shown at higher magnification in the inset.
Axons in wild-type SCG (D) are larger in diameter and
more completely ensheathed than those in
trkA / ganglia (E).
Magnification: A-C, 250×;
D, E, 15,000×.
[View Larger Version of this Image (194K GIF file)]
In addition to the principal sympathetic neurons, sympathetic ganglia
contain a subpopulation of cells of sympathoadrenal lineage known as
SIF cells. SIF cells, which are thought to be interneurons or
neuroendocrine cells (Elfvin et al., 1993 ), are smaller than principal
neurons (10-15 µm in diameter compared with 20-40 µm) and contain
many large dense-cored vesicles (Fig. 4C). Interestingly,
trkA / animals contain the normal complement
of these cells, which appear morphologically indistinguishable from
those of wild-type ganglia (Fig. 4C). Therefore, expression
of TrkA receptors appears to be required for the survival of principal
neurons, but not of SIF cells.
Sympathetic target innervation in normal and trkA null mice
The above results indicate that cell death within the SCG of
trkA / mice takes place after E13.5, the time
of scheduled onset of trkA expression. However, certain
developmental programs, such TH expression, appear to be independent of
the presence of TrkA receptors. Indeed, the SCGs of
trkA / mice exhibit normal levels of TH
immunoreactivity at both E13.5 and E15.5 (Fig. 5). To
determine whether TrkA receptors are required for other events of
sympathetic development, we examined whether the neurons of
trkA / SCGs extend axons that are capable of
reaching their targets. To this end, we assessed neurite outgrowth in
wild-type and trkA / SCGs using TH
immunocytochemistry because TH is localized in sympathetic axons as
well as cell bodies.
Fig. 5.
Immunocytochemical analysis of tyrosine
hydroxylase in the SCGs of wild-type and
trkA / mice. A,
B, Arrows indicate plexes of tyrosine
hydroxylase-positive fibers extending from the SCG, often in the
vicinity of the nearby vasculature (asterisk).
C, D, Arrows indicate
tyrosine hydroxylase-immunoreactive fibers exiting the SCG in bundles,
likely representing the nascent sympathetic nerves.
Asterisks identify a neighboring blood vessel. Scale
bars, 5 µm.
[View Larger Version of this Image (110K GIF file)]
A substantial number of TH-positive neurites could be observed
extending from the SCG in wild-type E13.5 embryos (Fig. 5A).
These fibers traveled a limited, albeit significant, distance toward
the neighboring vasculature, one of the first sympathetic targets to be
innervated (Rubin, 1985 ). No differences in neurite outgrowth were
observed between trkA / mice and their
wild-type littermates at this developmental stage (Fig. 5B).
Similar results were obtained when we analyzed mice at E15.5, a time
when trkA transcripts are highly expressed in the wild-type
animals (Fig. 5C,D). Bundles of
TH-immunoreactive fibers projecting from different areas of the
ganglion, likely representing the nascent postganglionic nerves, were
found in both wild-type and mutants SCGs (Fig.
5B,D). These observations suggest that
TrkA receptors are not required for initial sympathetic axonal
growth.
Next, we examined whether sympathetic axons in
trkA / mice were capable of innervating the
submaxillary gland, a more distal target. Coarse TH-immunoreactive
fibers were first observed in the wild-type submaxillary gland at E15.5
(Fig. 6A). From this time on, the
number of TH-positive fibers continues to increase until the entire
gland becomes densely innervated by P0 (Fig. 6B).
When sections from trkA / mutant mice were
examined, no significant levels of innervation could be detected in the
submaxillary gland throughout this period (Fig.
6B,D), despite the presence of
significant TH immunoreactivity in the surviving SCG neuronal cell
bodies of these animals. These results suggest that TrkA receptors are
required to sustain axonal growth to reach distal targets.
Fig. 6.
Tyrosine hydroxylase immunoreactivity in the
submaxillary gland of wild-type and
trkA / mice. A,
C, Arrows indicate innervating fibers of
sympathetic origin. Scale bar, 3 µm.
[View Larger Version of this Image (94K GIF file)]
SCG development in trkB / and
trkC / mice
Consistent with the lack of trkB expression in
embryonic and postnatal sympathetic neurons, no defects were observed
in the SCG of trkB / mice (data not shown).
However, trkC is abundantly expressed from E11.5 to E15.5
(see Fig. 1), thus raising the possibility that events in early
sympathetic development require NT-3/TrkC signaling. Indeed, mice
lacking NT-3 display a 50% reduction in the number of SCG neurons
(Ernfors et al., 1994 ; Fariñas et al., 1994 ; ElShamy et al.,
1996 ). Surprisingly, analysis of SCG neuron number in
trkC / mice revealed no significant
differences from their wild-type littermates during embryonic
development and at postnatal time points (Fig. 7). In
addition, trkC / SCG neurons exhibited normal
TH immunoreactivity and target innervation (data not shown). These
results suggest that TrkC receptors, although expressed during the
early stages of sympathetic development, are not essential for the
genesis or survival of sympathetic neurons in vivo.
Fig. 7.
Number of neurons in the SCG of wild-type
(filled squares) and
trkC / (open triangles)
mice. Values were obtained from at least six SCGs in each group for
each time point. No statistical differences between groups were found
using Student's t test (p < 0.05). Error bars correspond to SEM.
[View Larger Version of this Image (22K GIF file)]
Previous studies have demonstrated that NT-3 promotes the survival of
rat sympathetic neuroblasts in culture, whereas neurons from older
developmental stages require NGF (Birren et al., 1993 ; DiCicco-Bloom et
al., 1993 ). These observations have led to a model in which NT-3
signaling, presumably mediated by TrkC receptors, leads to a switch in
neurotrophin dependency by inducing expression of TrkA receptors (Verdi
and Anderson, 1994 ). To determine whether NT-3 signaling through TrkC
receptors triggers expression of TrkA receptors in vivo, we
examined the presence of trkA transcripts in the SCG of
trkC / mice at E15.5, a time of robust
trkA expression in the developing SCG. As illustrated in
Figure 8, A and B, we observed
normal levels of trkA gene expression in both wild-type and
trkC / E15.5 embryos. Likewise,
trkC expression was not affected in
trkA / embryos (Fig.
8C,D), indicating that, in
vivo, expression of the trkA and trkC genes
is not regulated by each other.
Fig. 8.
trkA and trkC
gene expression in the SCG of E15.5
trkC / and
trkA / embryos, respectively. Sections
derived from (A) wild-type and (B)
trkC / animals were submitted to
in situ hybridization using a probe specific for
trkA transcripts. Sections derived from
(C) wild-type and (D)
trkA / animals hybridized with a probe
specific for trkC transcripts. The SCG shown in
D appears larger than that in C because
they are in different planes of section. Scale bar, 10 µm.
[View Larger Version of this Image (69K GIF file)]
DISCUSSION
The generation of mice lacking each of the known neurotrophins and
their cognate receptors is making it possible to decipher the specific
role that these trophic factors play in the development of the
mammalian nervous system. In this study, we have analyzed the role of
each of the three members of the Trk family of receptors in the
development of sympathetic neurons. As previously observed in rats
(Ernfors et al., 1992 ; Birren et al., 1993 ; DiCicco-Bloom et al.,
1993 ), expression of Trk receptors in the mouse SCG is developmentally
regulated. TrkC transcripts appear in sympathetic neurons
before the coalescence of the SCG (E11.5). trkC expression
declines during late gestation and remains restricted to a small subset
of cells postnatally. trkA transcripts can be first detected
at E13.5/E14.5, a time that coincides with the requirement of
sympathetic neurons for NGF in vitro (Coughlin and Collins,
1985; Wyatt and Davies, 1995 ). trkA expression increases by
E15.5 and remains high into adulthood.
Previous studies have shown that newborn
trkA / mice have significantly fewer
sympathetic neurons than their wild-type littermates (Smeyne et al.,
1994 ). Our detailed analysis of neuron number, mitotic figures, and
pyknotic nuclei during embryogenesis and early postnatal development
indicates that loss of sympathetic neurons in these mice is
attributable to increased cell death and not to a defect in neuroblast
proliferation. Moreover, the observation that cell death in
trkA / mutant mice extends along a time
course parallel to that of their wild-type siblings (albeit in greater
magnitude) suggests an exacerbation of a normal process rather than an
impairment of any other developmental event(s). These observations are
consistent with the notion that NGF plays a role in promoting
sympathetic neuronal survival during late, but not early, embryogenesis
(Barde, 1989 ; Vogel, 1994 ).
In contrast to the devastating effects of ablating the trkA
gene on the survival of sympathetic principal neurons, SIF cell
development appears to be unaffected by the absence of TrkA receptors.
This observation is consistent with the concept that SIF cells and
principal sympathetic neurons have independent developmental histories
(Hall and Landis, 1991 ). Glial cells, although reduced in number in the
mutant ganglia, also appear morphologically normal. The reduced number
of glial cells is likely to be a consequence of the absence of
postnatal (~P5) glial proliferation, possibly attributable to the
absence of neuron-derived glial growth factors (such as neuregulins) in
the mutant mice (Carraway and Burden, 1995 ).
Sympathetic neurons of trkA / mice are not
impaired in their ability to extend neurites during early development.
In fact, numerous TH-positive fibers can be found extending from the
trkA / SCG at E13.5 and E15.5, in patterns
indistinguishable from those of age-matched controls. Elaborate plexes
of fibers were observed extending toward the neighboring vasculature at
E13.5. By E15.5, both wild-type and trkA /
mice display thick bundles of TH-positive fibers coursing along blood
vessels, the normal trajectory taken by developing sympathetic fibers
as they grow toward more distal targets (Shibamori et al., 1994 ). These
observations indicate that TrkA signaling is not required for initial
axonal outgrowth and possibly not for innervation of proximal vascular
targets during development.
In wild-type E15.5 embryos, sympathetic fibers have begun to reach more
distal targets, such as the submaxillary gland. In the
trkA / E15.5 embryos, however, we did not
observe TH-positive fibers in the submaxillary gland, despite abundant
TH expression within SCG neuron cell bodies and their proximal
processes. This defect in submaxillary gland innervation in the TrkA
mutant mice is not attributable to a slower rate of axonal growth
because immunocytochemical analysis of neonatal animals also showed
lack of TH-positive fibers in the submaxillary gland. Therefore,
sympathetic axons cannot reach this distal target in the absence of
TrkA receptors. Whereas we cannot rule out the possibility of a primary
defect in axon growth in trkA / animals, we
favor the hypothesis that defects in distal target innervation are a
direct consequence of the massive neuronal cell death in the developing
SCG. If so, sympathetic neurons lacking TrkA receptors, and therefore
devoid of trophic support, must die (or at least initiate cell death)
before their processes reach their distal targets.
Regardless of the mechanism(s) responsible for the lack of distal
target innervation in the trkA / mice, our
results indicate that sympathetic neurons require trophic support
before reaching these distal targets. These observations are
at variance with certain aspects of the neurotrophic hypothesis, which
proposes that neurons become neurotrophin-dependent after target
innervation, thus allowing target-derived trophic factors to control
the number of neurons that will survive in the adult animal. Whereas
our results do not challenge this fundamental tenet, they suggest that
NGF may control sympathetic neuron number as part of a developmental
program independent of complete target innervation. Similar results
have been obtained recently when we analyzed sensory neurons of the
dorsal root ganglia (DRG). In this case, the peak of neuronal cell
death was observed at E13.5, a time when projections from the
trkA-expressing DRG sensory neurons have not reached their
distal cutaneous targets (White et al., 1996 ). Whether innervation of
proximal targets, such as the nearby vasculature in the case of
sympathetic neurons, plays a role in providing trophic support before
neighboring neurons reach their distal targets is a possibility that
remains to be explored.
A number of in vitro studies have indicated that rat
sympathetic neuroblasts undergo a developmental switch in their
neurotrophin dependence, from NT-3 to NGF (Birren et al., 1993 ;
DiCicco-Bloom et al., 1993 ; Verdi and Anderson, 1994 ). The sequential
expression of trkC and trkA transcripts within
the developing mouse SCG is consistent with this hypothesis. However,
our in vivo studies do not support the hypothesis that NT-3
signaling induces expression of TrkA receptors (Verdi and Anderson,
1994 ). Instead, our studies using mice defective in either TrkA or TrkC
receptors indicate that regulation of the genes encoding these
receptors is independent of the presence of each other.
Another unexpected observation reported in this study is the lack of
neuronal deficits in the SCG of trkC / mice.
The presence of abundant trkC transcripts during the early
developmental stages of sympathetic development suggests a critical
role for TrkC receptors. Moreover, mice defective in its cognate
ligand, NT-3, display a 50% reduction in SCG neurons (Ernfors et al.,
1994 ; Fariñas et al., 1994 ; ElShamy et al., 1996 ). Indeed, the
observed differences between NT-3 and trkC mutant mice may
not be limited to the sympathetic system since overall, the phenotype
of NT-3 / mice is substantially more severe than that of
trkC / animals (Ernfors et al., 1994 ;
Fariñas et al., 1994 ; Klein et al., 1994 ). It could be argued
that these differences might be attributable to the possible presence
of noncatalytic TrkC receptor isoforms in the
trkC / mice (Klein et al., 1994 ). However,
this hypothesis is unlikely since these receptors do not mediate NT-3
signaling, at least in vitro (Tsoulfas et al., 1993 ;
Valenzuela et al., 1993 ).
It is possible that some of the defects observed in the
NT-3 / , but not in the trkC / ,
mice might be attributed to NT-3 signaling through TrkA and/or TrkB
receptors. It has been reported recently that, in vitro,
NT-3 supports the survival of sensory and sympathetic neurons derived
from mice lacking signaling TrkC receptors (Davies et al., 1995 ).
Moreover, sympathetic neurons from mice lacking NGF reach the
submaxillary gland, although they do not form secondary processes (H. Phillips and S. Landis, unpublished observations), thus suggesting that
a neurotrophin other than NGF can support, at least partially,
sympathetic axonal growth through TrkA receptors. Recently, ElShamy et
al. (1996) have reported that the reduced number of postmitotic neurons
in the homozygous NT-3 mutant mice is caused by apoptosis of
sympathetic neuroblasts at E11.5. These observations raise the
possibility that NT-3 may act through TrkA receptors at a developmental
stage before the onset of NGF expression (E14.5-E15.5). However, no
such apoptotic events were observed in sympathetic neuroblasts of
trkA / mice, indicating that NT-3 cannot
signal exclusively through TrkA receptors at this time in
development.
A more likely scenario is that NT-3 can signal through either TrkA or
TrkC receptors during the short developmental window in which these
receptors are coexpressed throughout the developing SCG. If so, loss of
the neurotrophic factor NT-3, but not of only one of the two
receptors TrkA or TrkC, would result in neuronal deficits. This
hypothesis can be tested by comparing the number of apoptotic
neuroblasts in NT-3 / mice versus those in mice lacking
TrkA and TrkC receptors. However, only 1 of 16 embryos
derived from crosses between double heterozygous
trkA+/ ;trkC+/
mice would yield the desired phenotype. Moreover, the presence of
apoptotic neuroblasts in these double-knockout embryos will be obscured
by the onset of neuronal cell death caused by the absence of TrkA
receptors.
Analysis of genetically engineered mice lacking neurotrophins and their
signaling Trk receptors is making it possible to analyze neuronal
development, at least in the peripheral nervous system, with a degree
of detail and sophistication that was not possible before. These
studies are likely to expand and refine hypotheses drawn in
vitro and in vivo studies using conventional mice. The
demonstration that TrkC receptors are not essential for SCG development
despite their expression in early embryos and the observation that
sympathetic neurons of trkA / mice do not
innervate distal targets are just two examples of the value of these
mutant mice to study the development of the mammalian nervous system.
FOOTNOTES
Received April 22, 1996; revised July 16, 1996; accepted July 18, 1996.
This work was supported in part by National Institutes of Health Grant
HD 25681 to S.C.L. We thank M. Garber, A. Lewin, L. Long, C. Marks, J. D. Wallace, and J. Wolf for their excellent technical assistance.
Correspondence should be addressed to Mariano Barbacid, Bristol-Myers
Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ
08543-4000.
Dr. Fagan's present address: Department of Neurology, Washington
University School of Medicine, St. Louis, MO 63110.
Dr. Smeyne's present address: St. Jude Children's Research Hospital,
Memphis, TN 38101.
REFERENCES
-
Barbacid M
(1994)
The Trk family of neurotrophin
receptors.
J Neurobiol
25:1386-1403 .
[Web of Science][Medline]
-
Barde YA
(1989)
Trophic factors and neuronal survival.
Neuron
2:1525-1534 .
[Web of Science][Medline]
-
Birren S,
Liching L,
Anderson DJ
(1993)
Sympathetic
neuroblasts undergo a developmental switch in trophic dependence.
Development
119:597-610 .
[Abstract]
-
Chao MV (1994) The p75 neurotrophin receptor. J
Neurobiol 25: 1373-1385.
-
Carraway KL,
Burden SJ
(1995)
Neuregulins and their
receptors.
Curr Opin Neurobiol
5:606-612 .
[Web of Science][Medline]
-
Chun LL,
Patterson PH
(1977)
Role of nerve growth factor in
the development of rat sympathetic neurons in vitro. II.
Developmental studies.
J Cell Biol
75:705-711 .
[Abstract/Free Full Text]
-
Coughlin MD,
Boyer DM,
Black IB
(1977)
Embryonic development
of a mouse sympathetic ganglion in vivo and in
vitro.
Proc Natl Acad Sci USA
74:3438-3442 .
[Abstract/Free Full Text]
-
Crowley C,
Spencer SD,
Nishimura MC,
Chen KS,
Pitts-Meek S,
Armanini MP,
Ling LH,
McMahon SB,
Shelton DL,
Levinson AD,
Phillips HS
(1994)
Mice lacking nerve growth factor display perinatal
loss of sensory and sympathetic neurons yet develop basal forebrain
cholinergic neurons.
Cell
76:1-20.
[Web of Science][Medline]
-
Davies AM,
Minichiello L,
Klein R
(1995)
Developmental
changes in NT-3 signalling via TrkA and TrkB in embryonic neurons.
EMBO J
14:4482-4489 .
[Web of Science][Medline]
-
DiCicco-Bloom E,
Friedman WJ,
Black IB
(1993)
NT-3 stimulates
sympathetic neuroblast proliferation by promoting precursor survival.
Neuron
11:1101-1111 .
[Web of Science][Medline]
-
Elfvin LG,
Lindh B,
Hokfelt T
(1993)
The chemical
neuroanatomy of sympathetic ganglia.
Annu Rev Neurosci
16:471-507 .
[Web of Science][Medline]
-
Elkabes S,
Dreyfus CF,
Schaar DG,
Black IB
(1994)
Embryonic
sensory development: local expression of neurotrophin-3 and target
expression of nerve growth factor.
J Comp Neurol
341:204-213 .
[Web of Science][Medline]
-
ElShamy WM,
Linnarsson S,
Lee K-F,
Jaenisch R,
Ernfors P
(1996)
Prenatal and postnatal requirements of NT-3 for
sympathetic neuroblast survival and innervation of specific targets.
Development
122:491-500 .
[Abstract]
-
Ernfors P,
Merlio JP,
Persson H
(1992)
Cells expressing mRNA
for neurotrophins and their receptors during embryonic rat development.
Eur J Neurosci
4:1140-1158.
[Web of Science][Medline]
-
Ernfors P,
Lee K-F,
Kucera J,
Jaenisch R
(1994)
Lack of
neurotrophin-3 leads to deficiencies in the peripheral nervous system
and loss of limb proprioceptive afferents.
Cell
77:503-512 .
[Web of Science][Medline]
-
Ernsberger U,
Degar D,
Rohrer H
(1989)
The survival of early
chick sympathetic neurons in vitro is dependent on a
suitable substrate but independent of NGF.
Dev Biol
135:250-262 .
[Web of Science][Medline]
-
Fariñas I,
Jones KR,
Backus C,
Wang XY,
Reichardt LF
(1994)
Severe sensory and sympathetic deficits in mice
lacking neurotrophin-3.
Nature
36:658-661.
-
Gorin PD,
Johnson EM
(1980)
Effects of long-term nerve growth
factor deprivation on the nervous system of the adult rat: an
experimental autoimmune approach.
Brain Res
198:27-42 .
[Web of Science][Medline]
-
Hall AK,
Landis SC
(1991)
Principal neurons and small
intensely fluorescent (SIF) cells in the rat superior cervical ganglion
have distinct developmental histories.
J Neurosci
11:472-484 .
[Abstract]
-
Hall AK,
Landis SC
(1992)
Division and migration of satellite
glia in the embryonic rat superior cervical ganglion.
J Neurocytol
21:635-647 .
[Web of Science][Medline]
-
Hendry IA
(1977)
Cell division in the developing sympathetic
nervous system.
J Neurocytol
6:299-309 .
[Web of Science][Medline]
-
Klein R,
Smeyne RJ,
Wrurst W,
Long LK,
Auerbach BA,
Joyner AL,
Barbacid M
(1993)
Targeted disruption of the trkB
neurotrophin receptor gene results in nervous system lesion and
neonatal death.
Cell
75:1-20.
[Web of Science][Medline]
-
Klein R,
Silos-Santiago I,
Smeyne RJ,
Lira SA,
Brambilla R,
Bryant S,
Zhang L,
Snider WD,
Barbacid M
(1994)
Disruption of the
neurotrophin-3 receptor gene trkC eliminates Ia muscle
afferents and results in abnormal movements.
Nature
368:249-251 .
[Medline]
-
Korsching S
(1993)
The neurotrophic factor concept: a
reexamination.
J Neurosci
13:2739-2748 .
[Abstract]
-
Lamballe F,
Tapley P,
Barbacid M
(1993)
trkC encodes multiple
neurotrophin-3 receptors with distinct biological properties and
substrate specificities.
EMBO J
12:3083-3094 .
[Web of Science][Medline]
-
Levi-Montalcini R,
Angeletti PU
(1966)
Immunosympathectomy.
Pharmacol Rev
18:619-628 .
[Free Full Text]
-
Levi-Montalcini R,
Booker B
(1960)
Destruction of the
sympathetic ganglia in mammals by an antiserum to a nerve-growth
protein.
Proc Natl Acad Sci USA
46:384-391.
[Free Full Text]
-
Rubin E
(1985)
Development of the rat superior cervical
ganglion: ganglion cell maturation.
J Neurosci
5:673-684 .
[Abstract]
-
Schecterson LC,
Bothwell M
(1992)
Novel roles for
neurotrophins are suggested by BDNF and NT-3 mRNA expression in
developing neurons.
Neuron
9:449-463 .
[Web of Science][Medline]
-
Shibamori Y,
Tamamaki N,
Saito H,
Nojyo Y
(1994)
The
trajectory of the sympathetic nerve fibers to the rat cochlea as
revealed by anterograde and retrograde WGA-HRP tracing.
Brain Res
646:223-229 .
[Web of Science][Medline]
-
Smeyne RJ,
Klein R,
Schnapp A,
Long LK,
Bryant S,
Lewin A,
Lira S,
Barbacid M
(1994)
Severe sensory and sympathetic
neuropathies in mice carrying a disrupted Trk/NGF receptor gene.
Nature
368:246-249 .
[Medline]
-
Snider WD
(1994)
Functions of the neurotrophins during
nervous system development: what the knockouts are teaching us.
Cell
77:627-638 .
[Web of Science][Medline]
-
Tsoulfas P,
Soppet D,
Escandon E,
Tessarollo L,
Mendoza-Ramirez JL,
Rosenthal A,
Nikolics K,
Parada LF
(1993)
The rat
trkC locus encodes multiple neurogenic receptors that
exhibit differential response to neurotrophin-3 in PC12 cells.
Neuron
10:975-990 .
[Web of Science][Medline]
-
Valenzuela DM,
Maisonpierre PC,
Glass DJ,
Rojas E,
Nunez L,
Kong Y,
Gies DR,
Stitt TN,
Ip NY,
Yancopoulos GD
(1993)
Alternative forms of rat TrkC with different
functional capabilities.
Neuron
10:963-974 .
[Web of Science][Medline]
-
Verdi JM,
Anderson DJ
(1994)
Neurotrophins regulate
sequential changes in neurotrophin receptor expression by sympathetic
neuroblasts.
Neuron
13:1359-1372 .
[Web of Science][Medline]
-
Vogel KS
(1994)
Development of trophic interactions in the
vertebrate peripheral nervous system.
Mol Neurobiol
7:363-382.
-
Vogel KS,
Davies AM
(1991)
The duration of neurotrophic
factor independence in early sensory neurons is matched to the time
course of target field innervation.
Neuron
7:819-830 .
[Web of Science][Medline]
-
White FA,
Silos-Santiago I,
Molliver DC,
Nismimura M,
Phillips H,
Barbacid M,
Snider WD
(1996)
Synchronous onset of NGF and
TrkA survival dependence in developing dorsal root ganglia.
J Neurosci
16:4662-4672 .
[Abstract/Free Full Text]
-
Wyatt S,
Davies AM
(1993)
Regulation of expression of mRNAs
encoding the nerve growth factor receptors p75 and trkA in developing
sensory neurons.
Development
119:635-647 .
[Abstract]
-
Wyatt S,
Davies AM
(1995)
Regulation of nerve growth factor
gene expression in sympathetic neurons during development.
J Cell Biol
130:1435-1446 .
[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
D. Bodmer, S. Levine-Wilkinson, A. Richmond, S. Hirsh, and R. Kuruvilla
Wnt5a Mediates Nerve Growth Factor-Dependent Axonal Branching and Growth in Developing Sympathetic Neurons
J. Neurosci.,
June 10, 2009;
29(23):
7569 - 7581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Brodeur, J. E. Minturn, R. Ho, A. M. Simpson, R. Iyer, C. R. Varela, J. E. Light, V. Kolla, and A. E. Evans
Trk Receptor Expression and Inhibition in Neuroblastomas
Clin. Cancer Res.,
May 15, 2009;
15(10):
3244 - 3250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Eldredge, X. M. Gao, D. H. Quach, L. Li, X. Han, J. Lomasney, and W. G. Tourtellotte
Abnormal sympathetic nervous system development and physiological dysautonomia in Egr3-deficient mice
Development,
September 1, 2008;
135(17):
2949 - 2957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Albers and B. M. Davis
The Skin as a Neurotrophic Organ
Neuroscientist,
August 1, 2007;
13(4):
371 - 382.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rassadi, A. Krishnaswamy, B. Pie, R. McConnell, M. H. Jacob, and E. Cooper
A Null Mutation for the {alpha}3 Nicotinic Acetylcholine (ACh) Receptor Gene Abolishes Fast Synaptic Activity in Sympathetic Ganglia and Reveals That ACh Output from Developing Preganglionic Terminals Is Regulated in an Activity-Dependent Retrograde Manner
J. Neurosci.,
September 14, 2005;
25(37):
8555 - 8566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. O. Glebova and D. D. Ginty
Heterogeneous Requirement of NGF for Sympathetic Target Innervation In Vivo
J. Neurosci.,
January 21, 2004;
24(3):
743 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W Munno and N. I Syed
Synaptogenesis in the CNS: An Odyssey from Wiring Together to Firing Together
J. Physiol.,
October 1, 2003;
552(1):
1 - 11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pelicci, F. Troglio, A. Bodini, R. M. Melillo, V. Pettirossi, L. Coda, A. De Giuseppe, M. Santoro, and P. G. Pelicci
The Neuron-Specific Rai (ShcC) Adaptor Protein Inhibits Apoptosis by Coupling Ret to the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway
Mol. Cell. Biol.,
October 15, 2002;
22(20):
7351 - 7363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Middleton and A. M. Davies
Populations of NGF-dependent neurones differ in their requirement for BAX to undergo apoptosis in the absence of NGF/TrkA signalling in vivo
Development,
December 1, 2001;
128(23):
4715 - 4728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Enomoto, P. A. Crawford, A. Gorodinsky, R. O. Heuckeroth, E. M. Johnson Jr., and J. Milbrandt
RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons
Development,
October 15, 2001;
128(20):
3963 - 3974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Plum, L. F. Parada, P. Tsoulfas, and M. Clagett-Dame
Retinoic Acid Combined with Neurotrophin-3 Enhances the Survival and Neurite Outgrowth of Embryonic Sympathetic Neurons
Experimental Biology and Medicine,
September 1, 2001;
226(8):
766 - 775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Edsjö, B. Hallberg, S. Fagerström, C. Larsson, H. Axelson, and S. Påhlman
Differences in Early and Late Responses between Neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y Neuroblastoma Cells
Cell Growth Differ.,
January 1, 2001;
12(1):
39 - 50.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Bibel and Y.-A. Barde
Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system
Genes & Dev.,
December 1, 2000;
14(23):
2919 - 2937.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Brodski, H. Schnürch, and G. Dechant
Neurotrophin-3 promotes the cholinergic differentiation of sympathetic neurons
PNAS,
August 6, 2000;
(2000)
160080697.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. D. Pozniak, S. Radinovic, A. Yang, F. McKeon, D. R. Kaplan, and F. D. Miller
An Anti-Apoptotic Role for the p53 Family Member, p73, During Developmental Neuron Death
Science,
July 14, 2000;
289(5477):
304 - 306.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. J. Kim, T. Matsuo, K.-H. Lee, and C. J. Thiele
Up-Regulation of Insulin-Like Growth Factor-II Expression Is a Feature of TrkA but Not TrkB Activation in SH-SY5Y Neuroblastoma Cells
Am. J. Pathol.,
November 1, 1999;
155(5):
1661 - 1670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wyatt, G. Middleton, E. Doxakis, and A. M. Davies
Selective Regulation of trkC Expression by NT3 in the Developing Peripheral Nervous System
J. Neurosci.,
August 1, 1999;
19(15):
6559 - 6570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sondell, G. Lundborg, and M. Kanje
Vascular Endothelial Growth Factor Has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival and Schwann Cell Proliferation in the Peripheral Nervous System
J. Neurosci.,
July 15, 1999;
19(14):
5731 - 5740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Debeir, H. U. Saragovi, and A. C. Cuello
A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat
PNAS,
March 30, 1999;
96(7):
4067 - 4072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. Lentz, C. M. Knudson, S. J. Korsmeyer, and W. D. Snider
Neurotrophins Support the Development of Diverse Sensory Axon Morphologies
J. Neurosci.,
February 1, 1999;
19(3):
1038 - 1048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-M. Yang, J. G. Toma, S. X. Bamji, D. J. Belliveau, J. Kohn, M. Park, and F. D. Miller
Autocrine Hepatocyte Growth Factor Provides a Local Mechanism for Promoting Axonal Growth
J. Neurosci.,
October 15, 1998;
18(20):
8369 - 8381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Oberdoerster, A. R. Kamer, and R. A. Rabin
Differential Effect of Ethanol on PC12 Cell Death
J. Pharmacol. Exp. Ther.,
October 1, 1998;
287(1):
359 - 365.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Zhang, M. F. Mehler, Q. Song, and J. A. Kessler
Development of Bone Morphogenetic Protein Receptors in the Nervous System and Possible Roles in Regulating trkC Expression
J. Neurosci.,
May 1, 1998;
18(9):
3314 - 3326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tessarollo, P. Tsoulfas, M. J. Donovan, M. E. Palko, J. Blair-Flynn, B. L. Hempstead, and L. F. Parada
Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis
PNAS,
December 23, 1997;
94(26):
14776 - 14781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Fagan, M. Garber, M. Barbacid, I. Silos-Santiago, and D. M. Holtzman
A Role for TrkA during Maturation of Striatal and Basal Forebrain Cholinergic Neurons In Vivo
J. Neurosci.,
October 15, 1997;
17(20):
7644 - 7654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Toledo-Aral, B. L. Moss, Z.-J. He, A. G. Koszowski, T. Whisenand, S. R. Levinson, J. J. Wolf, I. Silos-Santiago, S. Halegoua, and G. Mandel
Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons
PNAS,
February 18, 1997;
94(4):
1527 - 1532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Brodski, H. Schnurch, and G. Dechant
Neurotrophin-3 promotes the cholinergic differentiation of sympathetic neurons
PNAS,
August 15, 2000;
97(17):
9683 - 9688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Majdan, G. S. Walsh, R. Aloyz, and F. D. Miller
TrkA mediates developmental sympathetic neuron survival in vivo by silencing an ongoing p75NTR-mediated death signal
J. Cell Biol.,
December 24, 2001;
155(7):
1275 - 1286.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|